Phase II Clinical Trial to Evaluate the Safety and Feasibility of Senolytic Therapy in Alzheimer's Disease

Project Number
ADDF-25
Agency/Funding Organization
Alzheimer's Drug Discovery Foundation
Funding Year
2020
Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator
Orr, Miranda
Awardee State
Contact PI Country
Project Detail
FY Overall Cost
$3,000,000
Funding Organization
Agency/Funding Organization
Funding Organization Country